Generic valsartan typically costs between $13 and $44 for a 30-day supply without insurance, depending on dosage and pharmacy. That’s noticeably more than some competing blood pressure medications in the same class, like losartan, which can run as low as $0.09 per tablet compared to valsartan’s $0.28 to $0.48 per tablet. Several factors stack up to keep valsartan’s price higher than you might expect for a generic drug: a rocky history of recalls and supply disruptions, fewer manufacturers competing for your business, and how your insurance plan categorizes it.
The Recall That Disrupted Everything
Valsartan’s pricing story starts with a massive global recall in 2018. Regulators discovered that certain manufacturers had been producing valsartan contaminated with trace amounts of a probable carcinogen. The contamination was traced to changes in the manufacturing process for the active ingredient, most of which is produced overseas. Multiple generic versions were pulled from pharmacy shelves simultaneously, creating an immediate shortage.
That shortage didn’t just affect valsartan. As millions of patients switched to alternative blood pressure drugs, the sudden spike in demand triggered secondary shortages of other medications in the same drug class. Research published in CMAJ Open found that the system-wide ripple effects exposed serious weaknesses in how drugs are sourced and procured. Even after the recall was resolved, rebuilding a stable supply chain took time, and some manufacturers never re-entered the market.
Fewer Manufacturers, Less Price Competition
Generic drugs get cheaper when multiple companies compete to sell them. Valsartan has faced an unusual path on that front. When the original patent on brand-name Diovan expired in September 2012, the launch of generic versions was delayed by regulatory problems with the FDA. One company received first-to-file approval, granting it 180 days of exclusive marketing rights before other generics could enter, which kept prices elevated during that window.
The 2018 recall then knocked several manufacturers out of the market entirely. Rebuilding FDA-approved production lines is expensive and slow, so not every company that lost its approval bothered to come back. Fewer competitors means less downward pressure on price. While valsartan is available as a generic today, the number of active suppliers remains smaller than for older, less disrupted generics like losartan, which has had a longer stretch of uninterrupted multi-manufacturer competition driving its price down.
Raw Ingredient Costs and Global Sourcing
The active pharmaceutical ingredient in valsartan is primarily manufactured in India, which accounts for roughly 57% of global exports. This heavy concentration in one region makes the supply vulnerable to disruptions from regulatory actions, factory shutdowns, or trade policy changes. Recent transaction data from the global pharmaceutical marketplace shows that raw ingredient prices for valsartan have actually been falling, dropping over 71% in a recent 90-day period, with trading activity also declining. That suggests the raw material itself isn’t currently driving high consumer prices. The gap between falling ingredient costs and stable retail prices points to other links in the chain, like manufacturing, distribution, and pharmacy markups, absorbing the savings before they reach you.
How Valsartan Compares to Losartan
If you’re taking valsartan and wondering why your copay feels high, the comparison to losartan is worth understanding. Both are in the same drug class (ARBs) and treat high blood pressure and heart failure. At standard doses, losartan runs about $0.09 per tablet in bulk pricing, while valsartan costs $0.28 to $0.48 per tablet. That’s roughly three to five times more per pill.
The price gap exists largely because losartan went generic earlier, avoided the same scale of recalls, and has more manufacturers competing in the market. Your doctor may have specific clinical reasons for prescribing valsartan over losartan, since the two drugs aren’t identical in how they work at different doses or in certain heart failure scenarios. But if cost is a concern, it’s a reasonable conversation to have, because the savings from switching can be significant over a year of daily use.
Insurance Coverage and Tier Placement
Most major insurance formularies do cover generic valsartan tablets. On the 2026 Express Scripts National Preferred Formulary, for example, valsartan tablets and the combination valsartan/hydrochlorothiazide are both listed as preferred medications. Valsartan is even named as the preferred alternative to several more expensive brand-name blood pressure drugs. So in many cases, your insurance should cover it at a relatively low tier.
There are exceptions, though. The liquid solution form of valsartan is excluded from some formularies entirely, which means you’d pay full price out of pocket. Combination pills that pair valsartan with other active ingredients may also land on a higher tier depending on your plan. If your out-of-pocket cost seems unexpectedly high, it’s worth checking whether your specific formulation and dosage are on your plan’s preferred list, since even small differences in how the drug is categorized can change your copay substantially.
Ways to Lower Your Cost
The best available cash price for a 30-day supply of 160mg valsartan tablets is around $13, but that requires using a discount card or coupon program rather than paying the pharmacy’s standard retail price. Prices vary widely between pharmacies, sometimes by $20 or more for the same pill in the same city. Warehouse pharmacies and independent pharmacies tend to offer lower cash prices than chain drugstores.
If you have insurance but your copay is still high, check whether your plan has a mail-order pharmacy option, which often provides a 90-day supply at a lower per-pill cost. You can also ask your pharmacist to run both your insurance and a discount card price to see which comes out lower. In some cases, paying cash with a coupon actually beats the insured price, especially if you haven’t met your deductible yet.